Active LN and the presence of U1-RNP antibodies were linked to low BMD and osteoporosis among patients with SLE.

Scientists at the Jackson Laboratory (JAX) have developed an antibody-based therapy against influenza A virus (IAV), which they suggest could change the way the world fights flu, one of the deadliest ...

Neuromuscular blocking agents (NMBAs) are essential for surgical procedures and airway management—but they’re not without risks. Rocuronium, one of the most commonly used nondepolarizing NMBAs, is ...

Mothers with intrauterine transmission of human cytomegalovirus (CMV) to their newborns despite preconception immunity had higher levels of neutralizing antibodies but had weaker antibody-dependent ...

The biotechnology sector has experienced unprecedented growth and innovation in recent years. As we look at the landscape in 2025, it’s clear that biotech has become an integral part of the global ...

A new study shows how the single-molecule organization of receptors in a cellular context determines the function of antibodies, opening up new pathways for the development of cancer immunotherapies.

In recent years, major breakthroughs have been made in the development and treatment of small cell lung cancer (SCLC). Research has increasingly focused on the development of Delta-like ligand 3 (DLL3 ...

NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Medicovestor, Inc., a biotechnology company advancing next-generation antibody-drug conjugates (ADCs), announced today that the U.S. Food and Drug ...

1 Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States 2 Department of Pediatrics, Children’s Healthcare of Atlanta, Atlanta, GA, ...